PINK:ATRX

Adhera Therapeutics Stock Insider Trading

etoro logo Buy ATRX
*Your capital is at risk
$0.0001
+0 (+0%)
At Close: Jun 02, 2026

Adhera Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 2.23B and sold 1M ATRX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 2.23B shares
Sell 1M shares
90% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Apr 16, 2018
Sell
5% Demand Line of Credit
C-Conversion
Trieu Vuong
Executive Chairman
CEO / President 0
Value: $0
Apr 16, 2018
Buy
Series E Convertible Preferred Stock
A-Award
Trieu Vuong
Executive Chairman
CEO / President 2
Value: $1
Apr 16, 2018
Buy
Series E Convertible Preferred Stock
C-Conversion
Trieu Vuong
Executive Chairman
CEO / President 19
Value: $10
Apr 16, 2018
Buy
Series E Convertible Preferred Stock
C-Conversion
Trieu Vuong
Executive Chairman
CEO / President 35
Value: $17
Apr 16, 2018
Buy
Series E Convertible Preferred Stock
C-Conversion
Trieu Vuong
Executive Chairman
CEO / President 115
Value: $57
Apr 16, 2018
Buy
Series E Convertible Preferred Stock
P-Purchase
Trieu Vuong
Executive Chairman
CEO / President 163
Value: $81
Apr 16, 2018
Buy
Warrants to Purchase Common Stock
A-Award
Trieu Vuong
Executive Chairman
CEO / President 16 875
Value: $9K
Apr 16, 2018
Buy
Warrants to Purchase Common Stock
C-Conversion
Trieu Vuong
Executive Chairman
CEO / President 142 500
Value: $78.4K
Apr 16, 2018
Buy
Warrants to Purchase Common Stock
C-Conversion
Trieu Vuong
Executive Chairman
CEO / President 258 825
Value: $142.4K
Apr 16, 2018
Buy
Warrants to Purchase Common Stock
C-Conversion
Trieu Vuong
Executive Chairman
CEO / President 859 725
Value: $472.8K
Apr 16, 2018
Buy
Warrants to Purchase Common Stock
P-Purchase
Trieu Vuong
Executive Chairman
CEO / President 2 564 465
Value: $1.41M
Jan 03, 2018
Buy
Options to purchase common stock
A-Award
Blech Isaac
Director
Director 3 800
Value: $6K
Jan 03, 2018
Buy
Options to purchase common stock
A-Award
Williams Donald Allen
Director
Director 3 800
Value: $6K
Jan 03, 2018
Buy
Options to purchase common stock
A-Award
Ranker Philip C
Director
Director 3 800
Value: $6K
Jan 03, 2018
Buy
Options to purchase common stock
A-Award
Calais Philippe
Director
Director 3 800
Value: $6K
Jan 03, 2018
Buy
Options to purchase common stock
A-Award
Trieu Vuong
Executive Chairman
CEO / President 3 800
Value: $6K
Jan 03, 2018
Buy
Options to purchase common stock
A-Award
Trieu Vuong
Executive Chairman
CEO / President 3 800
Value: $6K
Jan 03, 2018
Buy
Options to purchase common stock
A-Award
Calais Philippe
Director
Director 3 800
Value: $6K
Jan 03, 2018
Buy
Options to purchase common stock
A-Award
Ranker Philip C
Director
Director 3 800
Value: $6K
Jan 03, 2018
Buy
Options to purchase common stock
A-Award
Williams Donald Allen
Director
Director 3 800
Value: $6K
Jan 03, 2018
Buy
Options to purchase common stock
A-Award
Blech Isaac
Director
Director 3 800
Value: $6K
Nov 22, 2017
Buy
$500,000 Convertible Promissory Note Due March 2018
Blech Isaac
Director
Director 0
Value: $0
Nov 22, 2017
Buy
$500,000 Convertible Promissory Note Due March 2018
Blech Isaac
Director
Director 0
Value: $0
Oct 12, 2017
Buy
Common Stock
J-Other
Weinstein Peter D.
Officer
Officer 0
Value: $0
Oct 12, 2017
Buy
Options to purchase common stock
A-Award
Weinstein Peter D.
Chief Legal Officer
Officer 60 000
Value: $144.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ADHERA THERAPEUTICS, INC.
Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana....
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE